MX363035B - Uso de una composicion que comprende aceite de pescado y jugo para el tratamiento de inflamacion. - Google Patents

Uso de una composicion que comprende aceite de pescado y jugo para el tratamiento de inflamacion.

Info

Publication number
MX363035B
MX363035B MX2015017457A MX2015017457A MX363035B MX 363035 B MX363035 B MX 363035B MX 2015017457 A MX2015017457 A MX 2015017457A MX 2015017457 A MX2015017457 A MX 2015017457A MX 363035 B MX363035 B MX 363035B
Authority
MX
Mexico
Prior art keywords
inflammation
composition
treatment
juice
fish oil
Prior art date
Application number
MX2015017457A
Other languages
English (en)
Other versions
MX2015017457A (es
Inventor
Sande Mathisen Janne
Original Assignee
Smartfish As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smartfish As filed Critical Smartfish As
Publication of MX2015017457A publication Critical patent/MX2015017457A/es
Publication of MX363035B publication Critical patent/MX363035B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof containing fruit or vegetable juices
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/10—Foods or foodstuffs containing additives; Preparation or treatment thereof containing emulsifiers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a el uso de una composición que comprende aceite de pescado con valor bajo de Totox y el jugo en una emulsión de aceite-en-agua en el tratamiento/resolución de la inflamación y/o enfermedades en las que una causa subyacente es la inflamación. La invención abarca dicha otra composición que comprende el ácido acetilsalicílico y/o derivados y/o análogos de los mismos. Además, la presente invención se relaciona con el uso combinado de una composición de la invención y un agente terapéutico para el tratamiento de enfermedades inflamatorias o enfermedades en las que una causa subyacente es la inflamación.
MX2015017457A 2013-06-27 2014-06-26 Uso de una composicion que comprende aceite de pescado y jugo para el tratamiento de inflamacion. MX363035B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO20130889 2013-06-27
PCT/NO2014/050116 WO2014209132A1 (en) 2013-06-27 2014-06-26 Use of a composition comprising fish oil and juice for the treatment of inflammation

Publications (2)

Publication Number Publication Date
MX2015017457A MX2015017457A (es) 2016-03-31
MX363035B true MX363035B (es) 2019-03-06

Family

ID=52142337

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015017457A MX363035B (es) 2013-06-27 2014-06-26 Uso de una composicion que comprende aceite de pescado y jugo para el tratamiento de inflamacion.

Country Status (11)

Country Link
US (1) US10130601B2 (es)
EP (2) EP3766507A1 (es)
JP (2) JP2016523905A (es)
KR (1) KR20160025015A (es)
CN (2) CN113558240A (es)
AU (1) AU2014299410B2 (es)
BR (1) BR112015032029B1 (es)
CA (1) CA2915804A1 (es)
HK (1) HK1221875A1 (es)
MX (1) MX363035B (es)
WO (1) WO2014209132A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4205546A1 (en) 2012-05-10 2023-07-05 Solutex NA LLC Oils with anti-inflammatory activity containing natural specialized proresolving mediators and their precursors
GB2542873A (en) * 2015-04-16 2017-04-05 Elc Man Llc Unit dose packages, compositions, and treatment regimens to deliver pro-resolution pathway stimulators to keratin surfaces
WO2017041094A1 (en) 2015-09-03 2017-03-09 Solutex Na Llc Compositions comprising omega-3 fatty acids, 17-hdha and 18- hepe and methods of using same
HK1253384A1 (zh) * 2015-12-03 2019-06-14 株式会社明治 营养组合物
NO20160913A1 (en) * 2016-05-27 2017-11-28 Smartfish As Use of a composition comprising marine oil and juice for improving muscle performance.
JP7689356B2 (ja) * 2017-01-18 2025-06-06 ウニヴェルジテート オートノマ デ バルセロナ 神経変性疾患及び／又は自己免疫性疾患の処置において使用するための抗炎症性脂質メディエーター
US11583511B2 (en) 2017-07-20 2023-02-21 Universitat Autonoma De Barcelona Maresins for use in the treatment of CNS injuries
KR20220010415A (ko) 2020-07-17 2022-01-25 대봉엘에스 주식회사 불포화 지방산을 특정 함량으로 포함하는 유지 조성물 및 이의 용도
WO2023110855A1 (en) * 2021-12-14 2023-06-22 Devintec Sagl Compositions for treating autoimmune arthritis

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440464B1 (en) * 1996-06-10 2002-08-27 Viva Life Science Nutritive composition for cardiovascular health containing fish oil, garlic, rutin, capsaicin, selenium, vitamins and juice concentrates
SE523211C2 (sv) * 2000-04-26 2004-04-06 Skaanemejerier Ekonomisk Foere Lipidkomposition omfattande en skyddande olja och en fleromättad fettsyra, emulsion innehållande en sådan komposition och förfarande för framställning av emulsionen
NO317310B1 (no) * 2003-02-28 2004-10-04 Bioli Innovation As Olje-i-vann emulsjonskonsentrat for ernaeringsformal, samt anvendelse derav.
GB0314624D0 (en) * 2003-06-23 2003-07-30 Advanced Bionutrition Europ Lt Inflammatory disease treatment
US20060172012A1 (en) * 2005-01-28 2006-08-03 Finley John W Anti-inflammatory supplement compositions and regimens to reduce cardiovascular disease risks
NO324262B1 (no) 2005-11-29 2007-09-17 Pharmalogica As Bruksklar sammensetning omfattende fiskeolje og juice og fremstilling av denne, samt en forseglet beholder.
US20070167395A1 (en) * 2006-01-17 2007-07-19 Isaac Eliaz Compositions and methods for treating diabetes
EP2004169B1 (en) * 2006-04-12 2012-08-08 Unilever PLC Oral composition comprising a polyunsaturated fatty acid and salicylic acid for obtaining an antiinflammatory effect in skin
EP2031983A2 (en) * 2006-06-23 2009-03-11 The Procter and Gamble Company Concentrated omega-3 fatty acids and mixtures containing them
DE202007013532U1 (de) * 2007-09-26 2007-12-13 Orthomol Pharmazeutische Vertriebs Gmbh Zusammensetzung enthaltende Phospholipide, geeignet zur Stärkung der Gehirn- und Gedächtnisfunktion
EP2247201B1 (en) * 2008-02-12 2016-11-30 Ambo Innovation LLC Food products containing omega-3 fatty acids
NO20081487L (no) * 2008-03-27 2009-09-28 Smartfish As Helsefremmende drikk
NO333013B1 (no) * 2009-07-06 2013-02-18 Smartfish As Sammensetning omfattende bioaktive aminosyrer eller derivater derav og marin olje i en stabil olje-i-vannemulsjon, og fremgangsmate for fremstilling av nevnte sammensetning.
EP2279667A1 (en) 2009-07-30 2011-02-02 Brudy Technology, S.L. Vegetable and marine oil or fat compositions enriched with DHA or EPA and C18 or higher fatty acid
AT511126B1 (de) * 2011-03-09 2014-09-15 Avl List Gmbh Elektrischer energiespeicher

Also Published As

Publication number Publication date
CA2915804A1 (en) 2014-12-31
JP2016523905A (ja) 2016-08-12
EP3013157A1 (en) 2016-05-04
JP2019094348A (ja) 2019-06-20
KR20160025015A (ko) 2016-03-07
US10130601B2 (en) 2018-11-20
MX2015017457A (es) 2016-03-31
CN113558240A (zh) 2021-10-29
BR112015032029B1 (pt) 2021-04-06
AU2014299410B2 (en) 2017-12-21
AU2014299410A1 (en) 2015-12-24
BR112015032029A2 (pt) 2017-07-25
CN105338826A (zh) 2016-02-17
HK1221875A1 (zh) 2017-06-16
US20160367510A1 (en) 2016-12-22
EP3013157A4 (en) 2016-12-28
EP3766507A1 (en) 2021-01-20
WO2014209132A1 (en) 2014-12-31

Similar Documents

Publication Publication Date Title
MX363035B (es) Uso de una composicion que comprende aceite de pescado y jugo para el tratamiento de inflamacion.
MX2015009105A (es) Composiciones en solucion solida y su uso en inflamacion cronica.
MX2019004616A (es) Métodos de uso de indazol-3-carboxamidas y su uso como inhibidores de la ruta de señalización de wnt/b-catenina.
CO7121328A2 (es) Composiciones de ester de ácido graso omega -3
MX2016006896A (es) Microcapsulas de lipidos que comprenden preferiblemente una substancia activa lipofilica y composicion que las contiene, su metodo de preparacion y su uso en dermatolgia y cosmetica.
DOP2015000246A (es) Derivados de oxopiridina sustituida y usos de los mismos en el tratamiento de trastornos cardiovasculares
BR112016025126A2 (pt) formulação líquida compreendendo composto neutralizante de gm-csf
CL2015002433A1 (es) Imidazopiridazinas sustituidas
BR112017022209A2 (pt) composição aquosa que compreende éster de ácido omega- aminocarboxílico e álcool graxo e seu uso
ECSP17038893A (es) Pirazolpiridinaminas como inhibidores de mknk1 y mknk2
CL2015001446A1 (es) Procedimiento de preparación de albumina humana con nivel de oxigeno disuelto reducido.
DOP2016000007A (es) Pirazolpiridinas sustituidas
CL2019000607A1 (es) Composición para aplicación tópica con actividad antifúngica.
DOP2016000118A (es) Tienopirimidinas como inhibidores mknk1 y mknk2
MX2022001796A (es) Metodos y composiciones para inhibir los sintomas asociados con la veisalgia.
AR096338A1 (es) (ciano-dimetil-metil)-isoxazoles y -[1,3,4]tiadiazoles
CO2019009020A2 (es) Derivados de pirazol como inhibidores de bromodominio.
BR112016013992A2 (pt) Composição cosmética
MX369778B (es) Potenciadores de solubilidad del agua a base de glucogeno.
MX2018015965A (es) Composicion de dos componentes.
CL2015003460A1 (es) Composiciones oftálmicas acuosas tópicas que contienen un derivado de 1h-indol-1-carboxamida y uso de estas para el tratamiento de una enfermedad oftálmica
CL2019003288A1 (es) Una combinación farmacéutica para el tratamiento de un cáncer.
CL2016000397A1 (es) Tratamiento contra el cáncer
BR112015030352A8 (pt) Composições que compreendem um álcool aromático e um antagonista do trpv-1 e usos dessas composições
CL2013003808A1 (es) Formulacion veterinaria que comprende un extracto etanolico de s. adenotrichius dc donde el extracto etanolico comprende un compuesto sesquiterpeno eremofilano de formula i; uso para prevenir, controlar o eliminar garrapatas o sus larvas en un animal o humano, y en el entorno de los mismos.